Compugen's COM701 (anti-PVRIG) Induces Potent Immune Activation in MSS-CRC Patients
Go back to Compugen's COM701 (anti-PVRIG) Induces Potent Immune Activation in MSS-CRC Patients| Compugen Ltd (NASDAQ: CGEN) | Delayed: 2.57 +0.01 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.56 | 52 Week High | $7.79 | |||
| Open | $2.56 | 52 Week Low | $4.32 | |||
| Day High | $2.58 | P/E | N/A | |||
| Day Low | $2.53 | EPS | $-0.36 | |||
| Volume | 18,488 | |||||
| Compugen Ltd (NASDAQ: CGEN) | Delayed: 2.57 +0.01 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.56 | 52 Week High | $7.79 | |||
| Open | $2.56 | 52 Week Low | $4.32 | |||
| Day High | $2.58 | P/E | N/A | |||
| Day Low | $2.53 | EPS | $-0.36 | |||
| Volume | 18,488 | |||||

